-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Downgrades Allstate to Neutral, Raises Price Target to $261

Benzinga·07/15/2026 10:58:47
Listen to the news
UBS analyst Brian Meredith downgrades Allstate (NYSE:ALL) from Buy to Neutral and raises the price target from $255 to $261.